Z-1612-2016 Class II Terminated
FDA device recall Z-1612-2016 was initiated by Philips Electronics North America Corporation on Apr 14, 2016 and is designated Class II. Reason for recall: MRx monitor/defibrillators could fail to charge because the therapy printed circuit board may have been loaded with an incorrect electronic component. The recall status is terminated (terminated Mar 27, 2019). Affected quantity: 17.
Recall details
- Product Type
- Devices
- Report Date
- May 11, 2016
- Initiation Date
- Apr 14, 2016
- Termination Date
- Mar 27, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17
Product description
HeartStart MRx Monitor/Defibrillator The HeartStart MRx is for use for the termination of ventricular tachycardia and ventricular fibrillation. The device is for use by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced cardiac support, or defibrillation. It must be used by or on the order of a physician.
Reason for recall
MRx monitor/defibrillators could fail to charge because the therapy printed circuit board may have been loaded with an incorrect electronic component.
Distribution pattern
Worldwide Distribution - US including OH, CA, NC and Internationally to China, Iraq, Japan, and Korea.
Code information
US00586611, US00589878, US00594232, US00588464, US00591080, US00594779, US00588657, US00592182, US00594913, US00589391, US00593861, US00595298, US00589472, US00594092, US00595443, US00589851, US00594168
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1612-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026